Chemoinformaics analysis of 3,4,5-TRIMETHOXYCINNAMIC-ACID
Molecular Weight | 238.239 | nRot | 5 |
Heavy Atom Molecular Weight | 224.127 | nRig | 8 |
Exact Molecular Weight | 238.084 | nRing | 1 |
Solubility: LogS | -2.449 | nHRing | 0 |
Solubility: LogP | 1.938 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 33.3851 |
nHD | 1 | BPOL | 20.1209 |
QED | 0.792 |
Synth | 1.866 |
Natural Product Likeliness | 0.557 |
NR-PPAR-gamma | 0.172 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.015 |
HIA | 0.024 |
CACO-2 | -4.7 |
MDCK | 0.0000126 |
BBB | 0.748 |
PPB | 0.742131 |
VDSS | 0.46 |
FU | 0.142312 |
CYP1A2-inh | 0.056 |
CYP1A2-sub | 0.913 |
CYP2c19-inh | 0.029 |
CYP2c19-sub | 0.263 |
CYP2c9-inh | 0.024 |
CYP2c9-sub | 0.436 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.244 |
CYP3a4-inh | 0.007 |
CYP3a4-sub | 0.129 |
CL | 7.233 |
T12 | 0.912 |
hERG | 0.023 |
Ames | 0.013 |
ROA | 0.093 |
SkinSen | 0.948 |
Carcinogencity | 0.315 |
EI | 0.806 |
Respiratory | 0.609 |
NR-Aromatase | 0.446 |
Antiviral | No |
Prediction | 0.591811 |